🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Bayer bid to buy Monsanto wins U.S. DoJ approval - WSJ

Published 09/04/2018, 19:33
© Reuters. Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE
BAYGN
-
MON
-

(Reuters) - German conglomerate Bayer AG's (DE:BAYGn) $62.5 billion bid to acquire U.S. seeds company Monsanto Co (N:MON) has won approval from the U.S. Justice Department, after the companies said they would sell off additional assets, the Wall Street Journal reported https://on.wsj.com/2GKhEGh on Monday.

The report said the department had reached an agreement in principle with the two companies in recent days, citing people familiar with the matter.

Bayer said in a statement it anticipated closing in the second quarter of 2018.

"We remain confident in our ability to obtain all necessary regulatory approvals and look forward to continuing to work diligently with regulators to support that process," it said.

The Department of Justice and Monsanto both declined to comment.

Last week, Monsanto said in an earnings report that it was confident the U.S. and other needed regulatory approvals would be secured in the second quarter of this year.

The company did not host a conference call with analysts to discuss the earnings, as is its usual practice, because of the pending merger.

European Union antitrust regulators had approved the deal in March.

© Reuters. Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE

Monsanto's shares jumped 6.5 percent on Monday afternoon.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.